11![Intersect ENT Appoints David Lehman General Counsel MENLO PARK, Calif., February 22, 2016 – Intersect ENT, Inc. (Nasdaq:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat Intersect ENT Appoints David Lehman General Counsel MENLO PARK, Calif., February 22, 2016 – Intersect ENT, Inc. (Nasdaq:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat](https://www.pdfsearch.io/img/55394ff27e4fbc245071ff32f51a73b7.jpg) | Add to Reading ListSource URL: propelopens.comLanguage: English |
---|
12![](https://www.pdfsearch.io/img/e4d864dbe1eb6d7d073d82e9ba176e43.jpg) | Add to Reading ListSource URL: propelopens.comLanguage: English - Date: 2016-05-18 00:34:16
|
---|
13![Intersect ENT Enrolls First Patient in Pivotal Study to Evaluate the NOVA Sinus Implant Novel Device May Broaden Patient Population for Steroid Releasing Implants Menlo Park, Calif. – July 8, 2015 – Intersect ENT, In Intersect ENT Enrolls First Patient in Pivotal Study to Evaluate the NOVA Sinus Implant Novel Device May Broaden Patient Population for Steroid Releasing Implants Menlo Park, Calif. – July 8, 2015 – Intersect ENT, In](https://www.pdfsearch.io/img/692915909638de02a69a1512fa2b96e2.jpg) | Add to Reading ListSource URL: propelopens.comLanguage: English - Date: 2015-07-08 11:49:34
|
---|
14![Intersect ENT Announces Positive Preliminary Clinical Results for the PROPEL Mini Steroid Releasing Implant in Patients with Frontal Sinus Disease Menlo Park, Calif. – August 17, 2015 – Intersect ENT, Inc. (Nasdaq:XE Intersect ENT Announces Positive Preliminary Clinical Results for the PROPEL Mini Steroid Releasing Implant in Patients with Frontal Sinus Disease Menlo Park, Calif. – August 17, 2015 – Intersect ENT, Inc. (Nasdaq:XE](https://www.pdfsearch.io/img/6f5235ba7e7f6755dd38700485959b51.jpg) | Add to Reading ListSource URL: propelopens.comLanguage: English - Date: 2015-08-17 10:01:39
|
---|
15![Intersect ENT Announces FDA Submission to Seek Expanded Indication of PROPEL Mini Steroid Releasing Implant to Treat Patients With Frontal Sinus Disease MENLO PARK, Calif.—September 29, 2015—Intersect ENT, Inc. (Nasd Intersect ENT Announces FDA Submission to Seek Expanded Indication of PROPEL Mini Steroid Releasing Implant to Treat Patients With Frontal Sinus Disease MENLO PARK, Calif.—September 29, 2015—Intersect ENT, Inc. (Nasd](https://www.pdfsearch.io/img/f8838e9d79365f4b0fdb78715614cbb8.jpg) | Add to Reading ListSource URL: propelopens.comLanguage: English - Date: 2015-09-29 20:19:21
|
---|
16![PROPEL® (mometasone furoate implant, 370 µg) Instructions For Use English (GB) CAREFULLY READ ALL INSTRUCTIONS PRIOR TO USE PROPEL® (mometasone furoate implant, 370 µg) Instructions For Use English (GB) CAREFULLY READ ALL INSTRUCTIONS PRIOR TO USE](https://www.pdfsearch.io/img/df8023a95b8bc0a31c55a6fab96a8018.jpg) | Add to Reading ListSource URL: propelopens.comLanguage: English - Date: 2015-10-02 18:10:06
|
---|
17![Intersect ENT Announces Positive Clinical Results from Three Studies Evaluating Steroid Releasing Implants Placed in the Physician’s Office Menlo Park, Calif. and Dallas, Texas – September 28, 2015 – Intersect ENT, Intersect ENT Announces Positive Clinical Results from Three Studies Evaluating Steroid Releasing Implants Placed in the Physician’s Office Menlo Park, Calif. and Dallas, Texas – September 28, 2015 – Intersect ENT,](https://www.pdfsearch.io/img/23e5746e802d7e07bb282a5001f924c3.jpg) | Add to Reading ListSource URL: propelopens.comLanguage: English - Date: 2015-09-28 08:35:28
|
---|
18![PROPEL® Mini (mometasone furoate implant, 370 µg) Instructions For Use English (GB) CAREFULLY READ ALL INSTRUCTIONS PRIOR TO USE STERILE: PROPEL® Mini (mometasone furoate implant, 370 µg) Instructions For Use English (GB) CAREFULLY READ ALL INSTRUCTIONS PRIOR TO USE STERILE:](https://www.pdfsearch.io/img/7420c6911173f5f9bcf422bbc32cbd03.jpg) | Add to Reading ListSource URL: propelopens.comLanguage: English - Date: 2015-10-02 18:10:08
|
---|
19![Patient Information NASONEX® [nā-zə-neks] (mometasone furoate monohydrate) Nasal Spray, 50 mcg FOR INTRANASAL USE ONLY Read the Patient Information that comes with NASONEX before you start using it and each time you g Patient Information NASONEX® [nā-zə-neks] (mometasone furoate monohydrate) Nasal Spray, 50 mcg FOR INTRANASAL USE ONLY Read the Patient Information that comes with NASONEX before you start using it and each time you g](https://www.pdfsearch.io/img/c533b54cafb99222e313d03fe0a19f17.jpg) | Add to Reading ListSource URL: www.merck.comLanguage: English - Date: 2015-03-26 19:23:33
|
---|
20![News Release Media Contacts: <FOR IMMEDIATE RELEASE> Elsy Tan, GO Communications News Release Media Contacts: <FOR IMMEDIATE RELEASE> Elsy Tan, GO Communications](https://www.pdfsearch.io/img/39448ba4fe7b0643ff160b8fa3113e51.jpg) | Add to Reading ListSource URL: www.msd-malaysia.comLanguage: English - Date: 2015-03-20 02:58:39
|
---|